Fibroblast growth factor receptor-3 (FGFR-3) inhibitors and methods of treatment
US8182815B2 · kind B2 · utility
1Cited by
4References
5Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Sep 19, 2011 |
| Grant date | May 22, 2012 |
| Priority date | — |
| Expiry date | Sep 19, 2031 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2317/92
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to an isolated antibody or fragment thereof, which specifically binds to human FGFR-3(IIIb) and FGFR-3(IIIc), or mutant forms thereof. Further embodiments include pharmaceutical compositions comprising the antibody and methods of using the antibody to treat cancer.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.